Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
Information source: Connolly, Stuart, M.D.
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Ventricular Tachycardia
Intervention: amiodarone beta blocker sotalol (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Connolly, Stuart, M.D. Official(s) and/or principal investigator(s): Stuart Connolly, Principal Investigator, Affiliation: McMaster University
Summary
This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta
blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for
spontaneous or inducible ventricular tachycardia or fibrillation
Clinical Details
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Primary outcome: ICD shock for any cause
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria: spontaneous or inducible ventricular tachycardia or fibrillation -
Exclusion Criteria:
-
Locations and Contacts
McMaster University, Hamilton, Ontario, Canada
Additional Information
Starting date: January 2001
Last updated: July 26, 2006
|